Chromocell Therapeutics (CHRO) SEC Filings & 10K Form

$1.60
+0.10 (+6.67%)
(As of 04/26/2024 ET)

Recent Chromocell Therapeutics SEC Filings

DateFilerForm TypeView
04/16/2024
3:48 PM
Chromocell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/12/2024
6:22 PM
Chromocell Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/09/2024
7:30 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:00 AM
Chromocell Therapeutics (Filer)
Form NT 10-K
03/21/2024
8:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:00 AM
Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
4:10 PM
Chromocell Therapeutics (Subject)
Motif Pharmaceuticals Ltd. (Filed by)
Form SC 13G
03/01/2024
4:13 PM
AME Equities LLC (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
03/01/2024
4:16 PM
Aperture Healthcare Ventures Ltd. (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
03/01/2024
4:19 PM
Benuvia Operations, LLC (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G
02/26/2024
5:36 PM
Chromocell Therapeutics (Subject)
Friedberg Ezra M (Filed by)
Form SC 13D
02/23/2024
4:12 PM
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:15 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:17 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:28 PM
Chromocell Therapeutics (Filer)
Form 424B4
02/20/2024
4:30 PM
Chromocell Therapeutics (Filer)
Form 424B4
02/15/2024
8:56 PM
Chromocell Therapeutics (Filer)
Form POS EX
02/15/2024
7:33 PM
Aperture Healthcare Ventures Ltd. (Reporting)
Chromocell Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:36 PM
Chromocell Therapeutics (Issuer)
Motif Pharmaceuticals Ltd. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:38 PM
Boswell Prayer Ltd. (Reporting)
Chromocell Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:25 PM
AME Equities LLC (Reporting)
Chromocell Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:31 PM
Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:02 PM
Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:06 PM
Balmoral Financial Group LLC (Reporting)
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:10 PM
Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:12 PM
Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
7:14 PM
Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
10:46 AM
Chromocell Therapeutics (Filer)
Form CERT
02/15/2024
10:35 AM
Chromocell Therapeutics (Filer)
Form 8-A12B
02/14/2024
11:15 PM
Chromocell Therapeutics (Filer)
Form EFFECT
02/12/2024
7:09 AM
Chromocell Therapeutics (Subject)
Form FWP
02/12/2024
7:02 AM
Chromocell Therapeutics (Filer)
Form S-1/A
02/06/2024
7:40 PM
Chromocell Therapeutics (Filer)
Form S-1/A
02/06/2024
7:43 PM
Chromocell Therapeutics (Subject)
Form FWP
01/16/2024
4:28 PM
Chromocell Therapeutics (Filer)
Form S-1/A
11/07/2023
8:23 PM
Chromocell Therapeutics (Subject)
Form FWP
10/25/2023
3:39 PM
Chromocell Therapeutics (Filer)
Form S-1/A
10/13/2023
6:34 PM
Chromocell Therapeutics (Filer)
Form S-1/A
10/16/2023
5:00 AM
Chromocell Therapeutics (Subject)
Form FWP
09/01/2023
3:59 PM
Chromocell Therapeutics (Filer)
Form S-1/A
07/19/2023
8:15 PM
Chromocell Therapeutics (Filer)
Form S-1/A
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.
06/30/2023
1:13 PM
Chromocell Therapeutics (Filer)
Form S-1/A
05/01/2023
3:16 PM
Chromocell Therapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:CHRO) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners